Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Midatech Pharma
Midatech Pharma
Activities:
Drug Delivery
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Research & Development
Nanofacturing consortium makes significant progress
Partners across Europe collaborate to establish a pilot line for the scale-up and production of nanopharmaceutical products
Research & Development
Midatech Pharma-led consortium wins €7.9m in funding
For project to scale-up manufacturing of gold nanoparticle-based therapeutics for diabetes and rare cancers
Research & Development
Midatech appoints Nick Robbins-Cherry as Finance Director
Strengthening the senior management team at the nanomedicines specialist
Research & Development
Midatech makes two appointments
Strengthening the Board and senior management team
You need to be a subscriber to read this article.
Click here
to find out more.
Drug Delivery
Helping the delivery of biotech-based therapies
Modern biotech-derived medicines require new methods to aid targeted delivery. Dr Sarah Houlton, looks at some of the novel nano-based technologies that are getting results
Drug Delivery
Midatech raises £10m to advance gold-nanoparticle technology
For diabetes and cancer treatment and to work to commercialise new applications in medical diagnostics and imaging
Research & Development
MidaSol Therapeutics signs research collaboration with major US pharmaceutical company
Midatech and MonoSol Rx joint venture to develop new treatment for diabetes
Subscribe now